1Martelli M, Campama A. Bisch of P:Secretion of matrix metalloproteinases by human endometrial cell in vitro [J]. J Reprod Fertil, 1993, 98: 67.
2Vincenet AJ, Zhang J, Ostor A, et al. Salamonsen LA:Matrix metalloproteinase-1 and -3 and mast cell are present in the endometrium of women using progestin-only contraceptives [J].Hum reprod, 2000, 15(1): 123.
3Lois A, salamonsen ed. Hormones and women's health, the reproductive years[J]. Charter 13. Australia:Harwood Academic.
4Heatle M K.The association between clinical and pathologicalfeatures in histologically identified chronicendometritis[J].Journal Obstetrics Gynaecology,2004,24(7):801.
5Sukhikh GT,Shurshalina AV,Veryasov VN.Immunomorphological char-acteristics of endometrium in women with chronic endometritis[J].Bull ExpBiol Med,2006,14(1):104.
6Munro MG,Critchley HO,Broder MS,et al.FIGO classification system(PALM-COEIN)for causes of abnormal uterine bleeding in nongravid women of reproductive age[J].Int J Gynaecol Obstet,2011,113:3-13.
7Africander DJ,Storbeck KH,Hapgood JP.A comparative study of the androgenic properties of progesterone and the progestins,medroxyprogesterone acetate(MPA)and norethisterone acetate(NET-A)[J].J Steroid Biochem Mol Biol,2014,143:404-415.
8Salehpour S,Tamimi M,Saharkhiz N.Comparison of oral dydrogesterone with suppository vaginal progesterone for luteal-phase support in in vitro fertilization(IVF):A randomized clinical trial[J].Iran J Reprod Med,2013,11:913-918.
9Repina MA,Korzo TM,Zinina TA.Effect of hormone replacement therapy with femoston on hemostasis in peri-and postmenopausal women[J].Med Sci Monit,2002,8:178-184.
